tiprankstipranks
Trending News
More News >
Revive Therapeutics Ltd (TSE:RVV)
:RVV
Canadian Market

Revive Therapeutics (RVV) Financial Statements

Compare
133 Followers

Revive Therapeutics Financial Overview

Revive Therapeutics's market cap is currently C$6.28M. The company's EPS TTM is C$; its P/E ratio is -0.58; Revive Therapeutics is scheduled to report earnings on November 28, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross ProfitC$ -248.00C$ -328.00C$ -434.00C$ -578.00C$ -775.00
Operating IncomeC$ -1.65MC$ -3.29MC$ -5.52MC$ -17.83MC$ -18.50M
EBITDAC$ -11.01MC$ -5.60MC$ -5.52MC$ -17.74MC$ -18.57M
Net IncomeC$ -11.01MC$ -5.62MC$ -6.32MC$ -17.83MC$ -20.20M
Balance Sheet
Cash & Short-Term InvestmentsC$ 24.56KC$ 773.07KC$ 2.09MC$ 3.92MC$ 16.60M
Total AssetsC$ 205.02KC$ 10.64MC$ 14.25MC$ 17.07MC$ 29.81M
Total DebtC$ 66.87KC$ 25.22KC$ 219.69KC$ 327.73KC$ 415.84K
Net DebtC$ 42.31KC$ -797.85KC$ -1.87MC$ -3.59MC$ -16.18M
Total LiabilitiesC$ 3.66MC$ 3.40MC$ 3.60MC$ 4.46MC$ 999.68K
Stockholders' EquityC$ -3.46MC$ 7.23MC$ 10.65MC$ 12.60MC$ 28.81M
Cash Flow
Free Cash FlowC$ -807.66KC$ -3.29MC$ -6.03MC$ -13.06MC$ -11.31M
Operating Cash FlowC$ -807.66KC$ -3.29MC$ -6.03MC$ -13.06MC$ -8.31M
Investing Cash FlowC$ -30.00KC$ 0.00C$ 0.00C$ 0.00C$ -2.72M
Financing Cash FlowC$ 39.15KC$ 1.98MC$ 4.20MC$ 376.35KC$ 26.24M
Currency in CAD

Revive Therapeutics Earnings and Revenue History

Revive Therapeutics Debt to Assets

Revive Therapeutics Cash Flow

Revive Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.